A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
Recruiting · NCT06252298 · Registry updated 2024-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2024-04-22 | NCT06252298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sinocelltech Ltd. | 32 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chaoyang Hospital ,Capital Medical University | Beijing | China | 1 |